Zimmer Biomet (ZBH) official guidance

Zimmer Biomet (ZBH) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.

See the full Filings Intelligence suite
ZBHZIMMER BIOMET HOLDINGS, INC.FY2026 · ends 2026-12-31
8 metrics1 lowered2 new3 maintained
earnings call · 2026-08-06 04:01:46 UTC
2026-08-06 04:01:46 UTC193Mlowered -0.8%-2.9% vs FY2025
As a result, we now anticipate having about 193 million fully diluted weighted average shares outstanding for 2026.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC194M – 195Mnew
For the full year, we expect adjusted net interest and other non-operating expenses to be approximately $295 million, our adjusted effective tax rate to be about 18%, and to end the year with about 194-195 million shares outstanding.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-08-06 04:01:46 UTC18%new287 bps vs FY2025
Our assumptions for full year net interest and other non-operating expense and tax rate remain unchanged at $295 million and 18%, respectively.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:46 UTC$8.47 – $8.59maintained
Taking all of this into account, we are increasing our adjusted earnings per share expectations for the year to a range of $8.47-$8.59, versus our prior guidance of $8.40-$8.55.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 10:30:57 UTC$8.47 – $8.59raised +0.6%
| Adjusted Diluted EPS(2) | $8.40 - $8.55 | $8.47 - $8.59 |
ZBH · EX-99.1 · Q2 FY2026
2026-08-05 10:30:16 UTCOpen source
2026-04-29 04:01:42 UTC$8.4 – $8.55maintained
We now expect adjusted EPS to be $8.40-$8.55 from the previous guide of $8.30-$8.45.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-04-28 10:31:00 UTC$8.4 – $8.55raised +1.2%
| Adjusted Diluted EPS(2) | $8.30 - $8.45 | $8.40 - $8.55 |
ZBH · EX-99.1 · Q1 FY2026
2026-04-28 10:30:16 UTCOpen source
2026-02-11 05:01:28 UTC$8.3 – $8.45maintained
We now expect full-year organic constant currency revenue growth for 2026 in the low single-digit range, or 1%-3% growth, with an adjusted EPS, earnings per share, of $8.30-$8.45, which includes the contribution from Paragon 28 beginning April 21st, the one-year anniversary of the deal closing.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-02-10 11:31:24 UTC$8.3 – $8.45new
| Adjusted Diluted EPS(2) | $8.30 - $8.45 |
ZBH · EX-99.1 · Q4 FY2025
2026-02-10 11:30:26 UTCOpen source
2026-08-06 04:01:46 UTC9% – 11%maintained9% – 11% vs FY2025
We continue to expect to grow free cash flow 9%-11%.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC9% – 11%raised +11.1%9% – 11% vs FY2025
We expect our free cash flow growth to be in the range of 9%-11% versus the previous guide of 8%-10%.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC8% – 10%new8% – 10% vs FY2025
In addition, we expect adjusted EPS of $8.30-$8.45, with free cash flow growth of 8%-10%, which would mark the fourth consecutive year of high single-digit or greater free cash flow growth, quickly approaching 80% free cash flow conversion.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-08-06 04:01:46 UTC50 bps50 bps vs FY2025
We continue to anticipate foreign exchange to be an approximate 50 basis point tailwind to the full year revenue growth.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 10:30:57 UTC0.5%0.5% vs FY2025
| Foreign Currency Exchange Impact | +0.5% | +0.5% |
ZBH · EX-99.1 · Q2 FY2026
2026-08-05 10:30:16 UTCOpen source
2026-04-29 04:01:42 UTC50 bps50 bps vs FY2025
We continue to anticipate an approximate 50 basis points FX tailwind to full year revenue growth, with the second quarter being about neutral at current rates and Paragon 28 to contribute around 100 basis points to reported sales growth in 2026 before being reflected in organic growth.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-04-28 10:31:00 UTC0.5%0.5% vs FY2025
| Foreign Currency Exchange Impact | +0.5% | +0.5% |
ZBH · EX-99.1 · Q1 FY2026
2026-04-28 10:30:16 UTCOpen source
2026-02-11 05:01:28 UTC50 bps50 bps vs FY2025
At current rates, we expect FX to be approximately a 50 basis point tailwind to full-year revenue growth, which includes approximately 250 basis points of tailwind in the first quarter.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-02-10 11:31:24 UTC0.5%new
| Foreign Currency Exchange Impact | +0.50% |
ZBH · EX-99.1 · Q4 FY2025
2026-02-10 11:30:26 UTCOpen source
2026-08-06 04:01:46 UTC71%maintained
For the full year, we continue to expect gross margin to be around 71%, and we now forecast operating margins to decline a little more than 50 basis points, reflecting the aforementioned investments in our U.S. commercial organization.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC71%raised +0.7%
As you think about gross margin for the full year, we still expect it to be down modestly versus prior year at around 71%, give or take.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC70% – 71%new
So we expect gross margins for 2026 to be in the range of 70%-71%.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-08-06 04:01:46 UTC$295Mnew
Our assumptions for full year net interest and other non-operating expense and tax rate remain unchanged at $295 million and 18%, respectively.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:46 UTCat most -50 bps-50 bps vs FY2025
For the full year, we continue to expect gross margin to be around 71%, and we now forecast operating margins to decline a little more than 50 basis points, reflecting the aforementioned investments in our U.S. commercial organization.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC-50 bpsmaintained-50 bps vs FY2025
We now expect 2026 operating margins to be better than anticipated, down slightly less than 50 basis points from 2025, which still contemplates lower growth margins, dilution from the Paragon 28 acquisition, and increased investments in our U.S. commercial channel.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC-50 bpsnew-50 bps vs FY2025
As we have discussed previously, we expect our operating margins to be down about 50 basis points from 2025, which contemplates lower gross margins, dilutions from the Paragon 28 acquisition, and increased investments in our U.S. commercial channel.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.Q3 FY2026 · ends 2026-09-30
1 metric
earnings call · 2026-08-06 04:01:46 UTC
2026-08-06 04:01:46 UTCdown slightly on a sequential basis
Within that, we anticipate third quarter operating margins to be down slightly on a sequential basis from the second quarter.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC-50 bpsnew
We anticipate operating margins in the second quarter of 2026 being down roughly 200 basis points from the second quarter of 2025, and the third quarter operating margins being down around 50 basis points sequentially from the second quarter.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.FY2026 · ends 2026-12-31
1 metric
earnings call · 2026-08-06 04:01:46 UTC
2026-08-06 04:01:46 UTCat least -100 bps-100 bps vs FY2025
The updated revenue guidance contemplates a healthy orthopedic procedural market and new product momentum balanced with the continued risk of disruption from our U.S. and international go-to-market changes and up to 100 basis points of pricing erosion.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC-100 bps – 0 bps-100 bps – 0 bps vs FY2025
Well, first of all, that is the range that we've been given for a while, you know, flat to 100 basis points. In 2025, we did better than that. There were a couple of one-time events in international markets. As we enter 2026, we guided, you know, flat to 100.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTCat least -100 bpsnew-100 bps vs FY2025
This guidance contemplates end-market growth in line with 2025, the risk of disruption from the U.S. Salesforce transition, continued evolution of our international go-to-market models, up to 100 basis points of pricing erosion, and a stable tariff and policy environment.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.H4 FY2026 · ends 2026-12-31
1 metric1 new
earnings call · 2026-08-06 04:01:46 UTC
2026-08-06 04:01:46 UTCa much better S.E.T. growth profilenew
Net-net, the second half of 2026, we expect to have a much better S.E.T. growth profile, but again, very pleased with the progress and congratulations to the team, especially Paragon 28, for a stellar performance in the second quarter.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.FY2026 · ends 2026-12-31
5 metrics4 raised
earnings call · 2026-08-06 04:01:46 UTC
2026-08-06 04:01:46 UTC110 bpsraised +10.0%110 bps vs FY2025
In addition, given Paragon 28's strong performance, it will contribute 110 basis points to full year reported sales growth, above our initial expectation of around 100 basis points.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTC100 bpsmaintained100 bps vs FY2025
We continue to anticipate an approximate 50 basis points FX tailwind to full year revenue growth, with the second quarter being about neutral at current rates and Paragon 28 to contribute around 100 basis points to reported sales growth in 2026 before being reflected in organic growth.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC100 bpsnew100 bps vs FY2025
We expect Paragon 28 to contribute around 100 basis points to reported sales growth in 2026 before being reflected in organic growth in April.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-08-06 04:01:46 UTCat most $1B105.3% vs FY2025
As previously announced, we now plan to repurchase up to $1 billion of shares this year, an increase of $250 million from our initial expectation.
ZBH · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-04-29 04:01:42 UTCat most $750M54% vs FY2025
Our guidance for interest expense, tax rate, and end of year shares outstanding, which we continue to assume up to $750 million of share repurchases, remains unchanged.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTCat most $750Mnew
This share count reflects a share buyback program in 2026 of up to $750 million.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-08-05 10:30:57 UTC2.3% – 3.3%raised +37.5%2.3% – 3.3% vs FY2025
| 2026 Organic Constant Currency Revenue Change(1) | 1.0% - 3.0% | 2.25% - 3.25% |
ZBH · EX-99.1 · Q2 FY2026
2026-08-05 10:30:16 UTCOpen source
2026-04-28 10:31:00 UTC1% – 3%maintained1% – 3% vs FY2025
| 2026 Organic Constant Currency Revenue Change(1) | 1.0% - 3.0% | 1.0% - 3.0% |
ZBH · EX-99.1 · Q1 FY2026
2026-04-28 10:30:16 UTCOpen source
2026-02-11 05:01:28 UTC1% – 3%maintained1% – 3% vs FY2025
We now expect full-year organic constant currency revenue growth for 2026 in the low single-digit range, or 1%-3% growth, with an adjusted EPS, earnings per share, of $8.30-$8.45, which includes the contribution from Paragon 28 beginning April 21st, the one-year anniversary of the deal closing.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
2026-02-10 11:31:24 UTC1% – 3%new1% – 3% vs FY2025
| 2026 Organic Constant Currency Revenue Change(1) | 1.0% - 3.0% |
ZBH · EX-99.1 · Q4 FY2025
2026-02-10 11:30:26 UTCOpen source
2026-08-05 10:30:57 UTC3.9% – 4.9%raised +25.7%3.9% – 4.9% vs FY2025
| 2026 Reported Revenue Change | 2.5% - 4.5% | 3.9% - 4.9% |
ZBH · EX-99.1 · Q2 FY2026
2026-08-05 10:30:16 UTCOpen source
2026-04-28 10:31:00 UTC2.5% – 4.5%maintained2.5% – 4.5% vs FY2025
| 2026 Reported Revenue Change | 2.5% - 4.5% | 2.5% - 4.5% |
ZBH · EX-99.1 · Q1 FY2026
2026-04-28 10:30:16 UTCOpen source
2026-02-10 11:31:24 UTC2.5% – 4.5%new2.5% – 4.5% vs FY2025
| 2026 Reported Revenue Change | 2.5% - 4.5% |
ZBH · EX-99.1 · Q4 FY2025
2026-02-10 11:30:26 UTCOpen source
2026-08-05 10:30:57 UTC3.4% – 4.4%raised +30.0%3.4% – 4.4% vs FY2025
| 2026 Constant Currency Revenue Change | 2.0% - 4.0% | 3.4% - 4.4% |
ZBH · EX-99.1 · Q2 FY2026
2026-08-05 10:30:16 UTCOpen source
2026-04-28 10:31:00 UTC2% – 4%maintained2% – 4% vs FY2025
| 2026 Constant Currency Revenue Change | 2.0% - 4.0% | 2.0% - 4.0% |
ZBH · EX-99.1 · Q1 FY2026
2026-04-28 10:30:16 UTCOpen source
2026-02-10 11:31:24 UTC2% – 4%new2% – 4% vs FY2025
| 2026 Constant Currency Revenue Change | 2.0% - 4.0% |
ZBH · EX-99.1 · Q4 FY2025
2026-02-10 11:30:26 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.Q2 FY2026 · ends 2026-06-30
1 metric1 lowered
earnings call · 2026-04-29 04:01:42 UTC
2026-04-29 04:01:42 UTC-200 bpslowered -300.0%-200 bps vs Q2 FY2025
We anticipate operating margins in the second quarter of 2026 being down roughly 200 basis points from the second quarter of 2025, and the third quarter operating margins being down around 50 basis points sequentially from the second quarter.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTC100 bpsnew
Operating margins in the first quarter are expected to be down about 100 basis points from the first quarter of 2025 before increasing sequentially by about 100 basis points into the second quarter.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.H4 FY2026 · ends 2026-12-31
1 metric1 new
earnings call · 2026-04-29 04:01:42 UTC
2026-04-29 04:01:42 UTCmid-single digitnew4% – 6% vs Q4 FY2025
All of that said, the expectation is that we're gonna be growing international mid-single digit in the second half of 2026.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.FY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-04-29 04:01:42 UTC
2026-04-29 04:01:42 UTCstrongly in the double-digit growth ratesmaintained10% – 19% vs FY2025
We expect to exit 2026 strongly in the double-digit growth rates.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source
2026-02-11 05:01:28 UTCdouble-digitnew10% – 19% vs FY2025
We have made a commitment that we're going to grow this business double-digit in 2026, early in 2026, but we like what we see.
ZBH · transcript · Q4 FY2025
2026-02-11 05:00:00 UTCOpen source
ZBHZIMMER BIOMET HOLDINGS, INC.FY2027
1 metric1 new
earnings call · 2026-04-29 04:01:42 UTC
2026-04-29 04:01:42 UTCat least 200new
In anticipation of the mBôs launch, we're increasing the number of robotic clinical sales representatives targeting to hire over 200 by the end of 2027.
ZBH · transcript · Q1 FY2026
2026-04-29 04:00:00 UTCOpen source